DECISION OF THE EEA JOINT COMMITTEE No 65/2024

of 15 March 2024

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1625]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2023/1755 of 11 September 2023 renewing the approval of the low-risk active substance fat distillation residues in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( 1 ) , as corrected by OJ L, 2023/90211, 22.12.2023 , is to be incorporated into the EEA Agreement.

(2) Commission Implementing Regulation (EU) 2023/1756 of 11 September 2023 renewing the approval of the low-risk active substance Cydia pomonella granulovirus (CpGV) in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Regulation (EU) 2023/1757 of 11 September 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bensulfuron, chlormequat, chlorotoluron, clomazone, daminozide, deltamethrin, eugenol, fludioxonil, flufenacet, flumetralin, fosthiazate, geraniol, MCPA, MCPB, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride, tebufenpyrad, thymol, and tritosulfuron ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028 ( 4 ) is to be incorporated into the EEA Agreement.

(5) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):

‘—

32023 R 1755 : Commission Implementing Regulation (EU) 2023/1755 of 11 September 2023 ( OJ L 224, 12.9.2023, p. 18 ), as corrected by OJ L, 2023/90211, 22.12.2023 ,

— 32023 R 1756 : Commission Implementing Regulation (EU) 2023/1756 of 11 September 2023 ( OJ L 224, 12.9.2023, p. 23 ),

— 32023 R 1757 : Commission Implementing Regulation (EU) 2023/1757 of 11 September 2023 ( OJ L 224, 12.9.2023, p. 28 ).’

The following indent is added in point 13zzze (Commission Implementing Regulation (EU) No 686/2012):

‘—

32023 R 1784 : Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 ( OJ L 229, 18.9.2023, p. 89 ).’

The following points are inserted after point 13zzzzzzzzzzzzzx (Commission Implementing Regulation (EU) 2023/741):

‘13zzzzzzzzzzzzzy.

32023 R 1755 : Commission Implementing Regulation (EU) 2023/1755 of 11 September 2023 renewing the approval of the low-risk active substance fat distillation residues in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L 224, 12.9.2023, p. 18 ), as corrected by OJ L, 2023/90211, 22.12.2023 .

13zzzzzzzzzzzzzz.

32023 R 1756 : Commission Implementing Regulation (EU) 2023/1756 of 11 September 2023 renewing the approval of the low-risk active substance Cydia pomonella granulovirus (CpGV) in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011 ( OJ L 224, 12.9.2023, p. 23 ).’

Article 2

The texts of Implementing Regulations (EU) 2023/1755, as corrected by OJ L, 2023/90211, 22.12.2023 , (EU) 2023/1756, (EU) 2023/1757 and (EU) 2023/1784 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 16 March 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 15 March 2024.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

( 1 ) OJ L 224, 12.9.2023, p. 18 .

( 2 ) OJ L 224, 12.9.2023, p. 23 .

( 3 ) OJ L 224, 12.9.2023, p. 28 .

( 4 ) OJ L 229, 18.9.2023, p. 89 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/1625/oj

ISSN 1977-0677 (electronic edition)